CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study

CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study

Introduction: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) commonly presents as a peri-implant effusion (seroma). CD30 (TNFRSF8) is a consistent marker of tumor cells but also can be expressed by activated lymphocytes in benign seromas. Diagnosis of BIA-ALCL currently includes...

Full description

Bibliographic Details
Main Authors: Victoria G. Zeyl, Haiying Xu, Imran Khan, Jason T. Machan, Mark W. Clemens, Honghua Hu, Anand Deva, Caroline Glicksman, Patricia McGuire, William P. Adams, David Sieber, Mithun Sinha, Marshall E. Kadin
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
CD30
lateral flow assay
lymphoma
diagnosis
screening
ELISA
Online Access:https://www.mdpi.com/2072-6694/15/21/5128

Internet

https://www.mdpi.com/2072-6694/15/21/5128

Similar Items